Greater care should be taken to report IOL problems

Article

Surgeons should take greater precaution when compiling patient safety incidence (PSI) reports for cataract surgical care.

A study published in Eye has proposed surgeons should take greater precaution when compiling patient safety incidence (PSI) reports for cataract surgical care.

Dr S. P. Kelly et al., Royal Bolton Hospital NHS Foundation Trust, Lancashire, UK, identified 164 PSI reports of incorrect IOL implantation in NHS care in England and Wales between 2003 and 2010. The information was gathered from the National Patient Safety Agency.

Of the patients involved in the study, 47 required further surgical intervention, 163 patients needed IOL exchange surgery and 62 reports didn't name any reason for wrong IOL implantation.

The casual reasons for cataract surgery error included inaccurate biometry, wrong IOL selection, transcription errors and handwriting misinterpretations. It was suggested that ophthalmic teams to consider these reasons in order to improve their practice.

IOL implant errors occur infrequently but it was found that they are a threat to quality of cataract care. The study suggests greater attention should be given when creating PSI reports.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.